| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.380 | 63.145 | 58.328 | 43.013 | 49.146 | 53.554 | 427 |
| Total Income - EUR | - | - | - | 7.380 | 64.020 | 58.615 | 43.212 | 50.174 | 53.554 | 427 |
| Total Expenses - EUR | - | - | - | 2.996 | 51.414 | 55.994 | 34.462 | 33.028 | 43.332 | 1.077 |
| Gross Profit/Loss - EUR | - | - | - | 4.383 | 12.605 | 2.621 | 8.750 | 17.146 | 10.222 | -650 |
| Net Profit/Loss - EUR | - | - | - | 4.162 | 10.710 | 912 | 7.486 | 16.136 | 8.832 | -650 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Extensii Gene De Vis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 602 | 295 | 0 | 584 | 366 | 146 | 0 |
| Current Assets | - | - | - | 26.775 | 25.256 | 55.568 | 26.916 | 71.110 | 54.294 | 52.102 |
| Inventories | - | - | - | 19.636 | 24.675 | 50.868 | 15.887 | 66.591 | 47.488 | 47.223 |
| Receivables | - | - | - | 2.539 | 63 | 4.074 | 323 | 2.486 | 225 | 0 |
| Cash | - | - | - | 4.600 | 518 | 626 | 10.707 | 2.034 | 6.581 | 4.879 |
| Shareholders Funds | - | - | - | 4.205 | 14.834 | 15.465 | 22.607 | 38.813 | 47.528 | 46.612 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 23.172 | 10.717 | 40.103 | 4.893 | 33.068 | 6.913 | 5.490 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Extensii Gene De Vis S.r.l.